Publications by Dr Suzannah Harnor - ePrints

Browsing publications by Dr Suzannah Harnor

Newcastle Authors	Title	Year
Dr Simon Hill Dr Michael Dunn Dr Celine Cano Dr Suzannah Harnor Dr Ian Hardcastle et al.	Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification	2018
Christopher Coxon Dr Suzannah Harnor Dr Mathew Martin Dr Benoit Carbain Professor Bernard Golding et al.	Cyclin-Dependent Kinase (CDK) Inhibitors; Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines	2017
Dr Suzannah Harnor Alfie Brennan Dr Celine Cano	Inhibition of the DNA-Dependent Protein Kinase for Cancer Therapy	2017
Dr Suzannah Harnor James Pickles Dr Celine Cano	Modulation of the DNA-Damage Response by Inhibitors of the Phosphatidylinositol 3-Kinase Related Kinase (PIKK) Family	2017
Dr Suzannah Harnor Alfie Brennan Dr Celine Cano	Targeting DNA-Dependent Protein Kinase for Cancer Therapy	2017
Dr Victorovich Zaytsev James Pickles Dr Suzannah Harnor Dr Alistair Henderson Mohammed Al Yasiri et al.	Concise syntheses of bridged morpholines	2016
Dr Susan Tudhope Dr Yan Zhao Dr Anita Wittner Annalisa Bertoli Santosh Adhikari et al.	Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels	2014
Dr Suzannah Harnor Dr Tommy Rennison Martin Galler Dr Celine Cano Professor Roger Griffin et al.	Synthesis of 3 '-deoxy-3'-fluorothymidine (FLT) 5 '-O-glucuronide: a reference standard for imaging studies with [¹⁸F]FLT	2014
Annalisa Bertoli Santosh Adhikari Dr Suzannah Harnor Dr Yan Zhao Professor John Lunec et al.	Validation studies with small-molecule modulators of the MDM2/MDMX-p53 binding interaction	2014
Dr Emma Haagensen Huw Thomas Ian Wilson Dr Suzannah Harnor Sara Payne et al.	The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [¹⁸F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing Mice	2013